Drug Plan Management, Prescription Drugs Canadian Insurer details on coverage for Wegovy for cardiovascular treatment February 1, 2025 GroupForce Benefit News January 2025 Tags: Canada, Cardiovascular indication, Insurance, semaglutide, Wegovy, weight loss What do you think? Show comments / Leave a comment Insights More Related Articles Advise, Insight, The Workplace UPDATING EMPLOYMENT AGREEMENTS? MAKE SURE THE NEW CONTRACT WILL HOLD UP Media Benefits Canada – 2026 Canadian Leadership Council on Drug Plan Partnerships Advise, Healthcare, Prescription Drugs, The Workplace The here and now of pharmacogenetic testing
